Great Point Partners 13F filings

NEUROGENE INC COM

1,004,291 sh

10,062 sh
1%

$51,118

$31,850

ALPINE IMMUNE SCIENCES INC COM

1,128,499 sh

-2,574,934 sh
-70%

$44,734

-$25,853

UroGen Pharma Ltd. COM

2,620,545 sh

$39,308

Abivax SA F Sponsored ADR Stock

2,488,483 sh

938,483 sh
61%

$35,585

$19,000

EVOLUS INC COM

2,450,000 sh

450,000 sh
23%

$34,300

$13,240

Pliant Therapeutics Inc. COM

1,851,864 sh

28,680 sh
2%

$27,593

-$5,425

APOGEE THERAPEUTICS INC COM

400,000 sh

$26,580

Aerovate Therapeutics Inc. COM

887,690 sh

-150,000 sh
-14%

$26,249

$2,766

VIRIDIAN THERAPEUTICS Common Stock

1,335,000 sh

1,335,000 sh
NEW

$23,376

AnaptysBio Inc.

976,981 sh

$22,002

Esperion Therapeutics Inc COM

8,000,000 sh

8,000,000 sh
NEW

$21,440

INSMED INC COM PAR $.01

775,585 sh

549,673 sh
243%

$21,042

$14,041

ARCELLX INC

300,000 sh

251,736 sh
522%

$20,865

$18,186

XENON PHARMACEUTICALS INC COM

456,148 sh

-143,852 sh
-24%

$19,637

-$7,999

MIND MEDICINE MINDMED INC COM NEW Stock

2,000,000 sh

2,000,000 sh
NEW

$18,800

DIANTHUS THERAPEUTICS INC COM

625,000 sh

625,000 sh
NEW

$18,750

OUTLOOK THERAPEUTICS INC COM Common Stock

1,480,000 sh

1,480,000 sh
NEW

$17,671

Amicus Therapeutics Inc

1,495,500 sh

215,000 sh
17%

$17,617

-$553

Ocular Therapeutix Inc

1,728,723 sh

1,028,723 sh
147%

$15,731

$12,609

Dynavax Technologies Corp

1,264,920 sh

1,264,920 sh
NEW

$15,698

CYTOKINETICS INC COM NEW

202,202 sh

-297,798 sh
-60%

$14,176

-$27,569

Optinose Inc

8,786,318 sh

-53,621 sh
-1%

$12,828

$1,424

JASPER THERAPEURITC, INC. Stock

407,550 sh

407,550 sh
NEW

$11,966

INTRA CELLULAR THERAPIES INC COM

150,000 sh

39,393 sh
36%

$10,380

$2,458

MERUS N V COM

223,288 sh

203,288 sh
1016%

$10,055

$9,505

VISTAGEN THERAPEUTICS ORD COM

1,858,735 sh

$9,814

Terns Pharmaceuticals Inc. COM

1,309,975 sh

$8,593

IMMUNOCORE HOLDINGS PLC-ADR (IMCR US) ADS

115,000 sh

-178,000 sh
-61%

$7,475

-$12,543

AUTOLUS THERAPEUTICS PLC SPON ADS

1,166,667 sh

1,166,667 sh
NEW

$7,443

PUMA BIOTECHNOLOGY INC COM

1,343,628 sh

250,355 sh
23%

$7,121

$2,387

ZURA BIO LTD CLASS A ORD SHS

2,757,740 sh

-537,260 sh
-16%

$7,087

-$8,301

HELIX ACQUISITION CORP II CL A ORD SHS

500,000 sh

500,000 sh
NEW

$5,200

AEGLEA BIOTHERAPEUTICS INC cs

125,000 sh

$4,741

Kyverna Therapeutics, Inc. Common Stock

150,000 sh

150,000 sh
NEW

$3,726

Arvinas Inc COM

71,113 sh

-162,969 sh
-70%

$2,936

-$6,699

Ultragenyx Pharmaceutical Inc

0 sh

-648,000 sh
-100%

$0

-$30,987

RAPT Therapeutics Inc.

0 sh

-1,099,753 sh
-100%

$0

-$27,329

Alkermes

0 sh

-875,044 sh
-100%

$0

-$24,274

Vaxcyte, Inc. COM

0 sh

-360,000 sh
-100%

$0

-$22,608

TOURMALINE BIO INC Common Stock

0 sh

-672,885 sh
-100%

$0

-$17,616

KARUNA THERAPEUTICS INC COM

0 sh

-30,250 sh
-100%

$0

-$9,574

Sarepta Therapeutics Inc

0 sh

-80,000 sh
-100%

$0

-$7,714

AXSOME THERAPEUTICS INC COM

0 sh

-4,963 sh
-100%

$0

-$395

Mural Oncology PLC Common / Ordinary Stock

0 sh

-11,509 sh
-100%

$0

-$68

Great Point Partners 13F filings

Holdings as of 2024-03-31